Chinook Therapeutics, Inc. Stock price
Equities
KDNY
US16961L1061
Biotechnology & Medical Research
Latest transcript on Chinook Therapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Noopur Liffick
IRC | Investor Relations Contact | - | 20-09-30 |
Valerie Fauvelle
LAW | General Counsel | - | - |
Sukhi Thethy
AUD | Comptroller/Controller/Auditor | - | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.03% | 227 M€ | +4.74% | - |
1st Jan change | Capi. | |
---|---|---|
+3.25% | 108B | |
+9.35% | 104B | |
+6.38% | 23.66B | |
-11.49% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-13.52% | 16.19B | |
+4.76% | 13.72B | |
+34.32% | 12.22B |